Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Imogen R. Brooks
Observed names:
I. Brooks,
Imogen Brooks,
Imogen R Brooks
Institution:
King's College London
Observed institutions:
Agency for Science, Technology and Research,
Guy's Hospital,
King's College London,
University of Manchester,
Institute of Molecular and Cell Biology
ORCID:
0000-0002-2715-614X
Observed ORCID:
0000-0002-2715-614X
OpenAlex ID:
A5005724110
Works
18
Awards
1
Functional genomics and the future of iPSCs in disease modeling
2022
·
Imogen R. Brooks
, Cristina M. Garrone
, et al.
·
Stem Cell Reports
·
56
PDF
ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation
2022
·
Adam Sheriff
, Ina Guri
, et al.
·
Scientific Reports
·
49
PDF
Regulation of TGFβ Signalling by TRPV4 in Chondrocytes
2021
·
Steven Woods
, Evelyn Humphreys
, et al.
·
Cells
·
29
PDF
Global translation during early development depends on the essential transcription factor PRDM10
2020
·
Brenda Y. Han
, Michelle K. Y. Seah
, et al.
·
Nature Communications
·
26
PDF
Challenges of Gene Editing Therapies for Genodermatoses
2023
·
Imogen R. Brooks
, Adam Sheriff
, et al.
·
International Journal of Molecular Sciences
·
24
PDF
Prime editing in mammals: From promise to practicalities
2025
·
Imogen R. Brooks
, Carina Graham
, et al.
·
Molecular Therapy — Nucleic Acids
·
8
Highly efficient biallelic correction of homozygous COL7A1 mutation using ABE8e adenine base editor
2023
·
Imogen R Brooks
, Yara Alrokh
, et al.
·
British Journal of Dermatology
·
3
PDF
P07 Optimizing DNA specificity and applicability of base and prime editors on COL7A1 variants causing recessive dystrophic epidermolysis bullosa
2023
·
Imogen Brooks
, Maria Rudnytska
, et al.
·
British Journal of Dermatology
·
2
Gene Editing Therapies for Genodermatoses
2021
·
Adam Sheriff
, Imogen Brooks
, et al.
·
CRC Press eBooks
·
1
O2 Innate immune dysregulation drives recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma
2026
·
Madalina Alexandru
, Imogen R Brooks
, et al.
·
British Journal of Dermatology
O14 Next-generation sequencing precision: on- and off-target analysis of gene editing in recessive dystrophic epidermolysis bullosa
2026
·
Aidin Kazemizadeh
, Imogen Brooks
, et al.
·
British Journal of Dermatology
Three’s company: Simultaneous trimodal genome engineering using orthologous Cas proteins
2024
·
Imogen R. Brooks
, Joanna Jacków-Malinowska
·
Molecular Therapy
O17 Highly efficient base editing of homozygous and heterozygous COL7A1 variants in fibroblasts from patients with recessive dystrophic epidermolysis bullosa using adenine base editor 8e mRNA system delivered via novel lipid nanoparticle formulations
2024
·
Ina Guri
, Imogen Brooks
, et al.
·
British Journal of Dermatology
P09 Next-generation sequencing: on-and off-target analysis of gene editing in fibroblasts from patients with recessive dystrophic epidermolysis bullosa
2024
·
Aidin Kazemizadeh
, Imogen Brooks
, et al.
·
British Journal of Dermatology
ESDR283 - Optimising specificity and applicability of base editing for COL7A1 mutations in recessive dystrophic epidermolysis bullosa
2022
·
Imogen Brooks
, Paulina Zebrowska
, et al.
ESDR268 - ABE8e adenine base editor corrects COL7A1 nonsense mutation efficiently and safely
2022
·
Adam Sheriff
, Ina Guri
, et al.
474 Ratio-dependent adenine base editing engenders highly efficient correction of RDEB mutations with minimal bystander mutations
2022
·
A. Sheriff
, I. Guri
, et al.
·
Journal of Investigative Dermatology
157 Comparing adenine base editing and CRISPR-Cas9 gene editing strategies to correct recurrent mutations in RDEB primary fibroblasts
2021
·
A. Sheriff
, S. Tekkela
, et al.
·
Journal of Investigative Dermatology
Show more works
View as search
Works count:
18
Citation count:
198
H-index:
6
I10-index:
5
Year
Topic
Type